Income tax expense · 2016–2025

Amneal Pharmaceuticals income tax expense

$11.3M−40.2% · FY2025

Amneal Pharmaceuticals (AMRX) reported $11.3M in income tax expense for fiscal 2025, −40.2% year on year.

$5.4M2016$2.0M2017−$1.4M2018$383M2019−$104M2020$11.2M2021$6.7M2022$8.5M2023$18.9M2024$11.3M2025
Amneal Pharmaceuticals — Income tax expense, 2016–2025
Fiscal yearIncome tax expenseChangeFiling
FY20252025-12-31$11.3M−40.2%Open →
FY20242024-12-31$18.9M+123.2%Open →
FY20232023-12-31$8.5M+26.9%Open →
FY20222022-12-31$6.7M−40.5%Open →
FY20212021-12-31$11.2M+$116MOpen →
FY20202020-12-31−$104M−$488MOpen →
FY20192019-12-31$383M+$385MOpen →
FY20182018-12-31−$1.4M−$3.4MOpen →
FY20172017-12-31$2.0M−63.0%Open →
FY20162016-12-31$5.4M—Open →

Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +8.5%

Income tax expense at companies of similar size

Full ranking by income tax expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Amneal Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/amneal-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Amneal Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/amneal-pharmaceuticals/income-tax-expense

BibTeX

@misc{companiesranked-en-company-amneal-pharmaceuticals-income-tax-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Amneal Pharmaceuticals income tax expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/amneal-pharmaceuticals/income-tax-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001723128-26-000011 · February 27, 2026

{{cite web |title=Amneal Pharmaceuticals income tax expense — 10-K (0001723128-26-000011) |url=https://www.sec.gov/Archives/edgar/data/1723128/000172312826000011/amrx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Amneal Pharmaceuticals overview